Dermatomyositis with peripheral nervous system involvement: Activation of vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) in vasculitic lesions

Internal Medicine

Volumn 42, Issue 12, 2003, Pages 1233-1239

  Matsui, Naoko ^a,b   Mitsui, Takao ^a   Endo, Itsuro ^a   Oshima, Yasushi ^a   Kunishige, Makoto ^a   Matsumoto, Toshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Takamatsu Municipal Hospital   (Japan)

Author keywords

Neuropathy; Vascular endothelial growth factor (VEGF); Vasculitis; VEGF receptors (VEGFRs)

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISOLONE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; BRAIN VASCULITIS; CASE REPORT; CLINICAL OBSERVATION; DERMATOMYOSITIS; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; MEDICAL ASSESSMENT; MUSCLE BIOPSY; NERVE BIOPSY; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PROTEIN ANALYSIS; RECEPTOR UPREGULATION; SKELETAL MUSCLE; SKIN BIOPSY; SURAL NERVE; VASCULITIS;

EID: 1642463411     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.1233     Document Type: Article

References (24)

1. Engel AG, Hohlfeld R, Banker BQ. The polymyositis and dermatomyositis syndromes. in: Myology, 2nd ed. Engel AG, Franzini-Armstrong C, Eds. 1994: 1335-1381.
2. Senator H. Über acute Polymyositis und Neuromyositis. Deutsche Med Wchnschr 19: 933-936, 1893 (in German).
3. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 292: 344-347, 1975.
4. Umaki Y, Mitsui T, Endo I, Akaike M, Matsumoto T. Apotosis-related changes in skeletal muscles of patients with mitochondrial disease. Acta Neuropathol (Berl) 103: 163-170, 2002.
5. Thomas D, Kinney MD, Mary M, Maher MD. Dermatomyositis. A study of five cases. Am J Pathol 16: 561-594, 1940.
6. McEntee WJ, Mancall EL. Neuromyositis: A reappraisal. Neurology 15: 69-75, 1965.
7. Barron KD, Fine DIM. Neuromyositis. J Nerv Ment Dis 128: 497-507, 1959.
8. Vogelgesang SA, Gutierrez J, Klipple GL, Katona IM. Polyneuropathy in juvenile dermatomyositis. J Rheumatol 22: 1369-1372, 1995.
9. Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 7: 259-270, 1996.
10. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107: 233-235, 1995.
11. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997.
12. Mustonen T, Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129: 895-898, 1995.
13. Sato K, Yamazaki K, Shizume K, et al. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J Clin Invest 96: 1295-1302, 1995.
14. Small D, Levenstein M, Kim E, et al. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91: 459-463, 1994.
15. Galland F, Karamysheva A, Pebusque MJ, et al. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 8: 1233-1240, 1993.
16. Fava RA, Olsen NJ, Spencer-Green G, et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180: 341-346, 1994.
17. Koch AE, Harlow LA, Haines GK, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152: 4149-4156, 1994.
18. Hamamichi Y, Ichida F, Yu X, et al. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: Its possible role in progression of coronary artery lesions. Pediatr Res 49: 74-80, 2001.
19. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
20. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 28: 1176-1179, 1994.
21. Hang J, Kong L, Gu JW, Adair TH. VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle. Am J Physiol 269: H1827-H1831, 1995.
22. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347: 702, 1996.
23. Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 21: 1390-1397, 1998.
24. Nakano A, Mitsui T, Endo I, Takeda Y, Ozaki S, Matsumoto T. Solitary plasmacytoma with VEGF overproduction: report of a patient with polyneuropathy. Neurology 56: 818-819, 2001.